Results 161 to 170 of about 1,472 (172)

Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus

Journal of Antimicrobial Chemotherapy, 2019
Hannelore I Bax, , Jurriaan E M De Steenwinkel   +2 more
exaly  

In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis

Antimicrobial Agents and Chemotherapy, 2017
S Ken Tanaka
exaly  

Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous Formulations

Clinical Infectious Diseases, 2019
Richard R Watkins, Stan Deresinski, Watkins Richard R   +2 more
exaly  

Omadacycline tosylate, Sarecycline hydrochloride, Rifamycin sodium, and Moxidectin

Journal of the American Pharmacists Association, 2019
Daniel A, Hussar, Elias B, Chahine
openaire   +2 more sources

Linezolid/meropenem/omadacycline

Reactions Weekly
openaire   +1 more source

Omadacycline for Bacterial Infections. Reply.

The New England journal of medicine, 2019
Lynne, Garrity-Ryan, Evan, Loh
openaire   +1 more source

Furosemide/omadacycline/propofol

Reactions Weekly
openaire   +1 more source

Omadacycline (Nuzyra) — A New Tetracycline Antibiotic

JAMA, 2019
openaire   +2 more sources

Omadacycline Tosylate

openaire   +1 more source

Profiling of omadacycline resistance in clinical MRSA: A nationwide genomic survey and in vitro evolutionary analysis

International Journal of Antimicrobial Agents
Feiteng Zhu, Mengzhen Chen, Hemu Zhuang   +2 more
exaly